MedTrace Logo

Clinical Performance of Stenfilcon A Versus Filcon II 3

NCT01808209 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-08-03

Study results available
· View outcomes & findings →

Summary

Clinical Performance of Stenfilcon vs. Filcon II 3

Conditions

  • Myopia

Interventions

DEVICE

stenfilcon A

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

DEVICE

filcon II 3

Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • James Wolffsohn, PhD · University of Aston Birmingham, West Midlands, United Kingdom

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-04-30
Completion
2013-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01808209 on ClinicalTrials.gov